SCHEMBL19796752

SCHEMBL19796752

C=CC(=O)OCCc1cc(-c2ccc(-c3ccc(CCCCC)cc3)c(F)c2F)ccc1OCCO

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
THRB P10828 7/20 0.44
CNR2 P34972 2/20 0.43
CNR1 P21554 1/20 0.43
RARB P10826 4/20 0.41
THRA P10827 5/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
GABRA1 P14867 1/20 0.37
GABRB2 P47870 1/20 0.37
RARA P10276 1/20 0.37
RARG P13631 1/20 0.37
PTPN11 Q06124 2/20 0.37
MPL P40238 2/20 0.36
PPARD Q03181 2/20 0.36
PTPN1 P18031 1/20 0.36
PTPN6 P29350 1/20 0.36
APAF1 O14727 1/20 0.36
MAPT P10636 1/20 0.36
MAPK1 P28482 1/20 0.36
HTT P42858 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19796744 0.92 RARB (0.46) THRBCNR2CNR1RARBTHRA
SCHEMBL17070539 0.91 THRB (0.44) THRBCNR2CNR1RARBTHRA
SCHEMBL19796763 0.89 THRB (0.48) THRBCNR2CNR1RARBTHRA
SCHEMBL19796749 0.89 RARB (0.47) THRBCNR2CNR1RARBTHRA
SCHEMBL19804539 0.85 THRB (0.44) THRBRARBKMT2ARARARARG
SCHEMBL19796750 0.84 RARB (0.46) THRBCNR2CNR1RARBTHRA
SCHEMBL19796742 0.83 THRB (0.44) THRBCNR2CNR1RARBTHRA
SCHEMBL19796751 0.83 THRB (0.44) THRBCNR2CNR1RARBTHRA
SCHEMBL19796293 0.83 CNR2 (0.41) THRBCNR2CNR1RARBGABRA1
SCHEMBL19796755 0.83 THRB (0.43) THRBCNR2CNR1RARBTHRA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180023001-A1 COMPOUND HAVING POLYMERIZABLE GROUP, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE JNC CORPORATION (JP) 2018-01-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180023001-A1 COMPOUND HAVING POLYMERIZABLE GROUP, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE SP1, C1S, AP3D1 THRB 4323/4885CNR2 1075/4885CNR1 320/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.